Dana-Farber/Boston Children's opens immunotherapy trial for children with leukemia

(Dana-Farber Cancer Institute) Dana-Farber/Boston Children's Cancer and Blood Disorders Center has joined a clinical trial of immunotherapy for children with relapsed or treatment-resistant acute lymphoblastic leukemia (ALL). Led by Memorial Sloan Kettering Cancer Center, the trial is one of several nationally that are evaluating an approach that triggers a patient's immune system to attack cancer. Dana-Farber/Boston Children's is the only New England site offering this experimental approach for...